Skip to main content
. 2024 Mar 4;18(1):107. doi: 10.1007/s11701-024-01863-4

Table 2.

Surgical outcomes in the study cohort (N = 382)

ORH (n = 51) LRH (n = 225) RRH (n = 106) H/X2 value P value
Operating time (min) 230.0 (205.0–260.0) 215.0 (180.0–257.0) 182.0 (155.0–210.0) 47.069 <0.001
231.9 ± 37.4 222.7 ± 56.9 184.3 ± 38.5
Estimated blood loss (mL) 400.0 (200.0–600.0) 100.0 (50.0–200.0) 80.0 (50.0–100.0) 104.699 <0.001
462.9 ± 274.1 148.4 ± 121.0 93.7 ± 78.6
Transfusion 7 (13.7%) 6 (2.7%) 6 (5.7%) 10.904 0.004
Return of bowel movement (d) 2.0 (2.0–3.0) 2.0 (2.0–2.0) 2.0 (2.0–2.0) 32.495 <0.001
2.45 ± 0.7 1.92 ± 0.6 1.90 ± 0.6
Postoperative hospital stay (d) 11.0 (9.0–14.0) 9.0 (8.0–13.0) 8.0 (7.0–10.0) 23.012 <0.001
11.3 ± 3.4 10.2 ± 3.1 9.3 ± 4.4
No. of lymph nodes retrieved 35 (29–43) 34 (27–44) 37 (28–44) 1.147 0.564
37 ± 13 36 ± 13 37 ± 13
Surgery-related nerve injury 2 (3.9%) 16 (7.1%) 6 (5.7%) 0.815 0.656
Injury to abdominal organ 0 (0.0%) 0 (0.0%) 3 (2.8%) 5.701 0.038
Urinary retention 7 (13.7%) 43 (19.1%) 35 (33.0%) 10.529 .005
Thrombosis 0 (0.0%) 6 (2.7%) 0 (0.0%) 3.005 0.172
Wound complication 16 (31.4%) 1 (0.4%) 0 (0.0%) 58.950 <0.001
Fistula 0 (0.0%) 3 (1.3%) 0 (0.0%) 1.155 0.710
Infection 25 (49.0%) 48 (21.3%) 20 (18.9%) 19.693 <0.001
Pelvic lymphocele 17 (33.3%) 48 (21.3%) 43 (40.6%) 13.886 0.001